Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Phase II Trial of Baby Exemestane vs Baby Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.

NCT06364267 is registered in ClinicalTrials.gov with Andrea DeCensi as lead sponsor.

NCT NCT06364267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06364267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Phase II Trial of Baby Exemestane vs Baby Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
Lead sponsor
Andrea DeCensi
Phase
Phase 2
Overall status
Recruiting
Start date
October 1, 2025
Completion date
January 31, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer